Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Gilead Sciences has expanded access to its HIV medicines through agreements with the Medicines Patent Pool Foundation (MPPF), a nonprofit supported by UNITAIDand the Indian drug firms Hetero Drugs, Matrix Laboratories, Ranbaxy Laboratories, and Strides Arcolab. Both MPPF and the companies gain the right to produce for the developing world three drugs in late-stage clinical trials: elvitegravir, an integrase inhibitor; cobicistat, an antiretroviral boosting agent; and the Quad, which combines four Gilead HIV medicines in a once-daily pill. In 2006, Gilead allowed several manufacturers to make generic versions of the HIV drugs Viread and Truvada.
This article has been sent to the following recipient: